Healthcare -
Biotechnology - NASDAQ - US
$ 1.135
-12 %
$ 4.72 M
Market Cap
-0.09
P/E
MBRX - OTHER FINANCING ACTIVITIES
Other Financing Activities MBRX - Moleculin Biotech, Inc.
485 K
LAST VALUE
248.21%
2 YEAR CAGR
89.21%
5 YEAR CAGR
0.00%
10 YEAR CAGR